×
EndeavorRx

Live Educational Webinars

Monthly starting September, 2021

Conferences
& Events

Register for upcoming events + sessions hosted by the EndeavorRx team.

October 26, 2021 — 6:00PM PT

Webinar: Pioneering Medicine With a New Therapeutic Class

Join us on October 26th, 2021, to discover how Akili Interactive Labs is harnessing the power of digital therapeutics in pediatrics to reimagine the way we can treat ADHD. This no-cost webinar will be hosted by Raun Melmed, MD, as we take a closer look at the research, technology, and intergalactic gameplay powering this game-changing treatment category.

Register now
September 12th, 2021 — 5:30PM PT

Webinar: Lorem ipsum dolor sit amet, adipiscing elit.

Sed tincidunt nulla dui, et vestibulum neque interdum ut. Fusce id ligula non velit lacinia dictum. Sed congue mauris eros, eu sodales sapien aliquam ac. Vestibulum dapibus efficitur sapien at aliquet. Etiam viverra nulla purus, id facilisis est vehicula at. Aliquam tristique, felis at pharetra porta, nunc odio gravida arcu, id rhoncus massa nibh et mauris.

Register now

Stay up to date with EndeavorRx

Curious about EndeavorRx and wondering if it’s right for your child? Just complete this form to get more information & receive our latest updates.

By submitting this form, you consent to Akili processing your data or personal information in accordance with our Privacy Notice and agree to the Terms of Use of our sites.

EndeavorRx:

Indications, Safety and Cautions

Indications:
EndeavorRx is a digital therapeutic indicated to improve attention function as measured by computer-based testing in children ages 8-12 years old with primarily inattentive or combined-type ADHD, who have a demonstrated attention issue. Patients who engage with EndeavorRx demonstrate improvements in a digitally assessed measure, Test of Variables of Attention (TOVA®), of sustained and selective attention and may not display benefits in typical behavioral symptoms, such as hyperactivity. EndeavorRx should be considered for use as part of a therapeutic program that may include clinician-directed therapy, medication, and/or educational programs, which further address symptoms of the disorder.

Safety:
Of 538 participants using EndeavorRx, 50 participants (9.3%) experienced treatment-related adverse events (probable, likely), and three participants experienced treatment-related adverse events with the digital control, in studies where a control was used. EndeavorRx associated adverse events included frustration (6.1%), headache (1.3%), dizziness (0.6%), emotional reaction (0.4%), nausea (0.4%), and aggression (0.2%). There were no serious adverse events. All adverse events were generally transient. Only 3 events led to device discontinuation, and no subject reported lasting or irreversible effects after discontinuation.

Cautions:
Rx only: Federal law restricts this device to sale by or on the order of a physician. EndeavorRx should only be used by the patient for whom the prescription was written. For medical questions, please contact your child’s healthcare provider. If you are experiencing a medical emergency, please dial 911. EndeavorRx is not intended to be used as a stand-alone therapeutic and is not a substitution for your child’s medication.

If your child experiences frustration, emotional reaction, dizziness, nausea, headache, eye-strain, or joint pain while playing EndeavorRx pause the treatment. If the problem persists contact your child’s healthcare provider. If your child experiences a seizure stop the treatment and contact your child’s healthcare provider.

EndeavorRx may not be appropriate for patients with photo-sensitive epilepsy, color blindness, or physical limitations that restrict use of a mobile device; parents should consult with their child’s healthcare provider.

Please follow all of your mobile device manufacturer’s instructions for the safe operation of your mobile device. For example, this may include appropriate volume settings, proper battery charging, not operating the device if damaged, and proper device disposal. Contact your mobile device manufacturer for any questions or concerns that pertain to your device.